Showing results (201-210 of 5,331) with videos related to
Sort By:
Pageof 534
The American Journal of Medicine|October 27, 2023
Systematic Review and Meta-Analysis of Randomized Trials Testing Interventions to Reduce Physician BurnoutAlyson Haslam, Jordan Tuia, Sarah L Miller, et al.JAMA Network Open|March 5, 2020
Patient Experience Captured by Quality-of-Life Measurement in Oncology Clinical TrialsAlyson Haslam, Diana Herrera-Perez, Jennifer Gill, et al.Journal of Cancer Policy|September 26, 2022
Estimation of time cost of anti-cancer drugs approved based on comparisons to best supportive care: A cross sectional analysisVinay Prasad, Timothée Olivier, Emerson Y Chen, et al.Cancer Medicine|March 22, 2022
Targeted therapy in lung cancer: Are we closing the gap in years of life lost?David J Benjamin, Alyson Haslam, Jenny Gill, et al.JAMA Internal Medicine|March 20, 2023
Clinical Trials Portfolio and Regulatory History of Idelalisib in Indolent Non-Hodgkin Lymphoma: A Systematic Review and Meta-analysisTitas Banerjee, Myung Sun Kim, Alyson Haslam, et al.European Journal of Cancer (Oxford, England : 1990)|July 31, 2024
The landscape of checkpoint inhibitors in oncologyAlyson Haslam, Myung Sun Kim, Josh Elbaz, et al.Journal of Cancer Policy|May 13, 2022
Characteristics of oncology podcasts: Attitudes, speakers, conflictsEmma Greenstreet Akman, Kerrington Powell, Alyson Haslam, et al.Archives of Gynecology and Obstetrics|November 5, 2008
Placental mesenchymal dysplasia: a potential misdiagnosed entityDaphne C Ang, Paula Andrea Rodríguez Urrego, Vinay PrasadJournal of Cancer Policy|June 9, 2024
Social media engagement of supportive care publications in oncologySruthi Ranganathan, David J Benjamin, Alyson Haslam, et al.Journal of Cancer Policy|May 13, 2022
Challenges with sex-specific subgroup analyses in oncology clinical trials for drug approvals between 2015-2020Kristina Jenei, Adam Raymakers, Daniel E Meyers, et al.Pageof 534